244 related articles for article (PubMed ID: 33599431)
1. The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial.
Doaei S; Bourbour F; Teymoori Z; Jafari F; Kalantari N; Abbas Torki S; Ashoori N; Nemat Gorgani S; Gholamalizadeh M
Pediatr Endocrinol Diabetes Metab; 2021; 27(1):12-18. PubMed ID: 33599431
[TBL] [Abstract][Full Text] [Related]
2. Effects of Omega-3-6-9 fatty acid supplementation on behavior and sleep in preterm toddlers with autism symptomatology: Secondary analysis of a randomized clinical trial.
Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Keim SA
Early Hum Dev; 2022 Jun; 169():105588. PubMed ID: 35644107
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.
Mazahery H; Conlon C; Beck KL; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Mugridge O; von Hurst PR
Trials; 2016 Jun; 17(1):295. PubMed ID: 27334138
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.
Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; El-Houfey AA; Othman HA; Bjørklund G; Jia F; Urbina MA; Abo-Elela MGM; Ahmad FA; Abd El-Baseer KA; Ahmed AE; Abdel-Salam AM
J Child Psychol Psychiatry; 2018 Jan; 59(1):20-29. PubMed ID: 27868194
[TBL] [Abstract][Full Text] [Related]
5. Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder.
Keim SA; Jude A; Smith K; Khan AQ; Coury DL; Rausch J; Udaipuria S; Norris M; Bartram LR; Narayanan AR; Rogers LK
J Autism Dev Disord; 2022 Dec; 52(12):5342-5355. PubMed ID: 35013866
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior.
Parellada M; Llorente C; Calvo R; Gutierrez S; Lázaro L; Graell M; Guisasola M; Dorado ML; Boada L; Romo J; Dulin E; Sanz I; Arango C; Moreno C
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1319-1330. PubMed ID: 28935269
[TBL] [Abstract][Full Text] [Related]
7. Inflammation (IL-1β) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; von Hurst PR
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121236
[TBL] [Abstract][Full Text] [Related]
8. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms.
Sheppard KW; Boone KM; Gracious B; Klebanoff MA; Rogers LK; Rausch J; Bartlett C; Coury DL; Keim SA
J Autism Dev Disord; 2017 Nov; 47(11):3358-3369. PubMed ID: 28748334
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).
James S; Montgomery P; Williams K
Cochrane Database Syst Rev; 2011 Nov; (11):CD007992. PubMed ID: 22071839
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore.
Ooi YP; Weng SJ; Jang LY; Low L; Seah J; Teo S; Ang RP; Lim CG; Liew A; Fung DS; Sung M
Eur J Clin Nutr; 2015 Aug; 69(8):969-71. PubMed ID: 25804268
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
[TBL] [Abstract][Full Text] [Related]
13. ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
Horvath A; Łukasik J; Szajewska H
J Nutr; 2017 Mar; 147(3):367-376. PubMed ID: 28077731
[No Abstract] [Full Text] [Related]
14. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial.
de la Torre-Aguilar MJ; Gomez-Fernandez A; Flores-Rojas K; Martin-Borreguero P; Mesa MD; Perez-Navero JL; Olivares M; Gil A; Gil-Campos M
Front Nutr; 2022; 9():790250. PubMed ID: 35425788
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in Autism and Supplementation Based on Omega-3 Polyunsaturated Fatty Acids: A Narrative Review.
Veselinović A; Petrović S; Žikić V; Subotić M; Jakovljević V; Jeremić N; Vučić V
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577816
[TBL] [Abstract][Full Text] [Related]
17. Omega 3 fatty acid treatment in autism.
Meiri G; Bichovsky Y; Belmaker RH
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):449-51. PubMed ID: 19702497
[TBL] [Abstract][Full Text] [Related]
18. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.
Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Moreno C; Durán-Cutilla M; Ayora M; González-Vioque E; de Matteis M; Hendren RL; Arango C; Parellada M
Pediatrics; 2019 Nov; 144(5):. PubMed ID: 31586029
[TBL] [Abstract][Full Text] [Related]
19. Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats.
Schiavi S; Carbone E; Melancia F; Buzzelli V; Manduca A; Campolongo P; Pallottini V; Trezza V
Nutr Neurosci; 2022 May; 25(5):898-911. PubMed ID: 32912100
[No Abstract] [Full Text] [Related]
20. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
